Astaxanthin in Liver Health and Disease: A Potential Therapeutic Agent

References

• HenriquezV, EscobarC, GalarzaJ, GimpelJ. Carotenoids in Microalgae. Subcell Biochem. 2016;79:219–237.27485224
   PubMedGoogle Scholar
• FassettRG, CoombesJS. Astaxanthin in cardiovascular health and disease. Molecules. 2012;17(2):2030–2048. doi:10.3390/molecules1702203022349894
   PubMed Web of Science ®Google Scholar
• ZhangL, WangH. Multiple mechanisms of anti-cancer effects exerted by astaxanthin. Mar Drugs. 2015;13(7):4310–4330. doi:10.3390/md1307431026184238
   PubMed Web of Science ®Google Scholar
• FassettRG, CoombesJS. Astaxanthin: a potential therapeutic agent in cardiovascular disease. Mar Drugs. 2011;9(3):447–465. doi:10.3390/md903044721556169
   PubMed Web of Science ®Google Scholar
• BrownDR, GoughLA, DebSK, SparksSA, McNaughtonLR. Astaxanthin in exercise metabolism, performance and recovery: a review. Front Nutr. 2017;4:76. doi:10.3389/fnut.2017.0007629404334
   PubMed Web of Science ®Google Scholar
• FakhriS, AbbaszadehF, DargahiL, JorjaniM. Astaxanthin: a mechanistic review on its biological activities and health benefits. Pharmacol Res. 2018;136:1–20. doi:10.1016/j.phrs.2018.08.01230121358
   PubMed Web of Science ®Google Scholar
• ParkerRS. Absorption, metabolism, and transport of carotenoids. FASEB J. 1996;10(5):542–551. doi:10.1096/fasebj.10.5.86210548621054
   PubMed Web of Science ®Google Scholar
• AmbatiRR, PhangSM, RaviS, AswathanarayanaRG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications–a review. Mar Drugs. 2014;12(1):128–152.24402174
   PubMed Web of Science ®Google Scholar
• MolinoA, MehariyaS, IovineA, et al. Extraction of astaxanthin and lutein from microalga haematococcus pluvialis in the red phase using CO(2) supercritical fluid extraction technology with ethanol as co-solvent. Mar Drugs. 2018;16(11).
   Web of Science ®Google Scholar
• HongME, ChoiHI, KwakHS, et al. Rapid selection of astaxanthin-hyperproducing Haematococcus mutant via azide-based colorimetric assay combined with oil-based astaxanthin extraction. Bioresour Technol. 2018;267:175–181. doi:10.1016/j.biortech.2018.07.03330014996
   PubMed Web of Science ®Google Scholar
• RammuniMN, AriyadasaTU, NimarshanaPHV, AttalageRA. Comparative assessment on the extraction of carotenoids from microalgal sources: astaxanthin from H. pluvialis and beta-carotene from D. salina. Food Chem. 2019;277:128–134. doi:10.1016/j.foodchem.2018.10.06630502128
   PubMed Web of Science ®Google Scholar
• PengJ, YuanJP, WangJH. Effect of diets supplemented with different sources of astaxanthin on the gonad of the sea urchin anthocidaris crassispina. Nutrients. 2012;4(8):922–934. doi:10.3390/nu408092223016124
   PubMed Web of Science ®Google Scholar
• MisawaN, SatomiY, KondoK, et al. Structure and functional analysis of a marine bacterial carotenoid biosynthesis gene cluster and astaxanthin biosynthetic pathway proposed at the gene level. J Bacteriol. 1995;177(22):6575–6584. doi:10.1128/JB.177.22.6575-6584.19957592436
   PubMed Web of Science ®Google Scholar
• PanL, WangH, GuK. Nanoliposomes as vehicles for astaxanthin: characterization, in vitro release evaluation and structure. Molecules. 2018;23(11):2822. doi:10.3390/molecules23112822
   PubMed Web of Science ®Google Scholar
• AstorgP, GradeletS, LeclercJ, SiessMH. Effects of provitamin A or non-provitamin A carotenoids on liver xenobiotic-metabolizing enzymes in mice. Nutr Cancer. 1997;27(3):245–249. doi:10.1080/016355897095145339101553
   PubMed Web of Science ®Google Scholar
• StewartJS, LignellA, PetterssonA, ElfvingE, SoniMG. Safety assessment of astaxanthin-rich microalgae biomass: acute and subchronic toxicity studies in rats. Food Chem Toxicol. 2008;46(9):3030–3036. doi:10.1016/j.fct.2008.05.03818588938
   PubMed Web of Science ®Google Scholar
• KatsumataT, IshibashiT, KyleD. A sub-chronic toxicity evaluation of a natural astaxanthin-rich carotenoid extract of Paracoccus carotinifaciens in rats. Toxicol Rep. 2014;1:582–588. doi:10.1016/j.toxrep.2014.08.00828962271
   PubMedGoogle Scholar
• VegaK, EdwardsJ, BeilsteinP. Subchronic (13-week) toxicity and prenatal developmental toxicity studies of dietary astaxanthin in rats. Regul Toxicol Pharmacol. 2015;73(3):819–828. doi:10.1016/j.yrtph.2015.10.01326493001
   PubMed Web of Science ®Google Scholar
• EdwardsJA, BellionP, BeilsteinP, RumbeliR, SchierleJ. Review of genotoxicity and rat carcinogenicity investigations with astaxanthin. Regul Toxicol Pharmacol. 2016;75:5–19. doi:10.1016/j.yrtph.2015.12.00926713891
   PubMed Web of Science ®Google Scholar
• SerebruanyV, MalininA, GoodinT, PashkowF. The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naive and aspirin-treated subjects with multiple risk factors for vascular disease. Am J Ther. 2010;17(2):125–132. doi:10.1097/MJT.0b013e31819cdbbd20305399
   PubMed Web of Science ®Google Scholar
• RaoAR, SindhujaHN, DharmeshSM, SankarKU, SaradaR, RavishankarGA. Effective inhibition of skin cancer, tyrosinase, and antioxidative properties by astaxanthin and astaxanthin esters from the green alga Haematococcus pluvialis. J Agric Food Chem. 2013;61(16):3842–3851. doi:10.1021/jf304609j23473626
   PubMed Web of Science ®Google Scholar
• SatohA, TsujiS, OkadaY, et al. Preliminary clinical evaluation of toxicity and efficacy of A new astaxanthin-rich haematococcus pluvialis extract. J Clin Biochem Nutr. 2009;44(3):280–284. doi:10.3164/jcbn.08-23819430618
   PubMed Web of Science ®Google Scholar
• TominagaK, HongoN, KaratoM, YamashitaE. Cosmetic benefits of astaxanthin on humans subjects. Acta Biochim Pol. 2012;59(1):43–47. doi:10.18388/abp.2012_216822428137
   PubMed Web of Science ®Google Scholar
• KarppiJ, RissanenTH, NyyssonenK, et al. Effects of astaxanthin supplementation on lipid peroxidation. Int J Vitam Nutr Res. 2007;77(1):3–11. doi:10.1024/0300-9831.77.1.317685090
   PubMed Web of Science ®Google Scholar
• OsterlieM, BjerkengB, Liaaen-JensenS. Plasma appearance and distribution of astaxanthin E/Z and R/S isomers in plasma lipoproteins of men after single dose administration of astaxanthin. J Nutr Biochem. 2000;11(10):482–490. doi:10.1016/S0955-2863(00)00104-211120445
   PubMed Web of Science ®Google Scholar
• FaillaML, ChitchumronchokchaiC, FerruzziMG, GoltzSR, CampbellWW. Unsaturated fatty acids promote bioaccessibility and basolateral secretion of carotenoids and alpha-tocopherol by Caco-2 cells. Food Funct. 2014;5(6):1101–1112. doi:10.1039/C3FO60599J24710065
   PubMed Web of Science ®Google Scholar
• Ranga RaoA, Raghunath ReddyRL, BaskaranV, SaradaR, RavishankarGA. Characterization of microalgal carotenoids by mass spectrometry and their bioavailability and antioxidant properties elucidated in rat model. J Agric Food Chem. 2010;58(15):8553–8559. doi:10.1021/jf101187k20681642
   PubMed Web of Science ®Google Scholar
• Harukazu FukamiKN, Sugiura-TomimoriN, SumidaM, KatanoK, NakaoM. Chemical synthesis of astaxanthin n-octanoic acid monoester and diester and evaluation of their oral absorbability. J Oleo Sci. 2006;55(12):653–656. doi:10.5650/jos.55.653
   Google Scholar
• ZuluagaM, GueguenV, Pavon-DjavidG, LetourneurD. Carotenoids from microalgae to block oxidative stress. Bioimpacts. 2017;7(1):1–3. doi:10.15171/bi.2017.0128546947
   PubMed Web of Science ®Google Scholar
• GrimmigB, KimSH, NashK, BickfordPC, Douglas ShytleR. Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration. Geroscience. 2017;39(1):19–32. doi:10.1007/s11357-017-9958-x28299644
   PubMed Web of Science ®Google Scholar
• KowshikJ, BabaAB, GiriH, Deepak ReddyG, DixitM, NaginiS. Astaxanthin inhibits JAK/STAT-3 signaling to abrogate cell proliferation, invasion and angiogenesis in a hamster model of oral cancer. PLoS One. 2014;9(10):e109114. doi:10.1371/journal.pone.010911425296162
   PubMed Web of Science ®Google Scholar
• KavithaK, KowshikJ, KishoreTK, BabaAB, NaginiS. Astaxanthin inhibits NF-kappaB and Wnt/beta-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer. Biochim Biophys Acta. 2013;1830(10):4433–4444. doi:10.1016/j.bbagen.2013.05.03223726989
   PubMed Web of Science ®Google Scholar
• LiJ, DaiW, XiaY, et al. Astaxanthin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells via inhibition of Nf-Kappab P65 and Wnt/Beta-Catenin in vitro. Mar Drugs. 2015;13(10):6064–6081. doi:10.3390/md1310606426404320
   PubMed Web of Science ®Google Scholar
• ChenJT, KotaniK. Astaxanthin as a potential protector of liver function: a review. J Clin Med Res. 2016;8(10):701–704. doi:10.14740/jocmr2672w27635173
   PubMedGoogle Scholar
• AsraniSK, DevarbhaviH, EatonJ, KamathPS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–171. doi:10.1016/j.jhep.2018.09.01430266282
   PubMed Web of Science ®Google Scholar
• MancusoA, PolitiF, MaringhiniA. Portal vein thromboses in cirrhosis: to treat or not to treat? Gastroenterology. 2018;154(3):758. doi:10.1053/j.gastro.2017.07.053
   PubMed Web of Science ®Google Scholar
• TsuchidaT, FriedmanSL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397–411. doi:10.1038/nrgastro.2017.3828487545
   PubMed Web of Science ®Google Scholar
• YangY, BaeM, KimB, ParkYK, KooSI, LeeJY. Astaxanthin prevents and reverses the activation of mouse primary hepatic stellate cells. J Nutr Biochem. 2016;29:21–26. doi:10.1016/j.jnutbio.2015.11.00526895661
   PubMed Web of Science ®Google Scholar
• IslamMA, Al MamunMA, FarukM, et al. Astaxanthin ameliorates hepatic damage and oxidative stress in carbon tetrachloride-administered rats. Pharmacognosy Res. 2017;9(Suppl 1):S84–S91. doi:10.4103/pr.pr_26_1729333048
   PubMed Web of Science ®Google Scholar
• YangY, KimB, ParkYK, KooSI, LeeJY. Astaxanthin prevents TGFbeta1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells. Biochim Biophys Acta. 2015;1850(1):178–185. doi:10.1016/j.bbagen.2014.10.01425450180
   PubMed Web of Science ®Google Scholar
• ZhuS, WangT, LuoF, et al. Astaxanthin inhibits proliferation and induces apoptosis of LX2 cells by regulating the miR29b/Bcl2 pathway. Mol Med Rep. 2019;19(5):3537–3547. doi:10.3892/mmr.2019.1002530896849
   PubMed Web of Science ®Google Scholar
• ShenM, ChenK, LuJ, et al. Protective effect of astaxanthin on liver fibrosis through modulation of TGF-beta1 expression and autophagy. Mediators Inflamm. 2014;2014:954502. doi:10.1155/2014/95450224860243
   PubMed Web of Science ®Google Scholar
• Hernandez-GeaV, Ghiassi-NejadZ, RozenfeldR, et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology. 2012;142(4):938–946. doi:10.1053/j.gastro.2011.12.04422240484
   PubMed Web of Science ®Google Scholar
• ZhaoQ, QinCY, ZhaoZH, FanYC, WangK. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis. Tohoku J Exp Med. 2013;229(1):35–43. doi:10.1620/tjem.229.3523238615
   PubMed Web of Science ®Google Scholar
• YangY, BaeM, ParkYK, et al. Histone deacetylase 9 plays a role in the antifibrogenic effect of astaxanthin in hepatic stellate cells. J Nutr Biochem. 2017;40:172–177. doi:10.1016/j.jnutbio.2016.11.00327915160
   PubMed Web of Science ®Google Scholar
• WuYJ, WuYC, ChenIF, et al. Reparative effects of astaxanthin-hyaluronan nanoaggregates against retrorsine-CCl(4)-induced liver fibrosis and necrosis. Molecules. 2018;23(4):726.
   PubMed Web of Science ®Google Scholar
• ChiuCH, ChangCC, LinST, ChyauCC, PengRY. Improved hepatoprotective effect of liposome-encapsulated astaxanthin in lipopolysaccharide-induced acute hepatotoxicity. Int J Mol Sci. 2016;17(7):1128. doi:10.3390/ijms17071128
   PubMed Web of Science ®Google Scholar
• FarrellGC, WardellR, TeohN, ChitturiS. Non-alcoholic fatty liver disease. Intern Med J. 2019;49(5):681–683. doi:10.1111/imj.1428331083812
   PubMed Web of Science ®Google Scholar
• SundelinEIO, GormsenLC, HeebollS, et al. Hepatic exposure of metformin in patients with non-alcoholic fatty liver disease. Br J Clin Pharmacol. 2019. doi:10.1111/bcp.13962
   PubMed Web of Science ®Google Scholar
• MooreJB, ThorneJL. Predicting and reducing hepatic lipotoxicity in non-alcoholic fatty liver disease. Lab Anim (NY). 2019;48(5):143–144. doi:10.1038/s41684-019-0291-031000821
   PubMed Web of Science ®Google Scholar
• IkeuchiM, KoyamaT, TakahashiJ, YazawaK. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem. 2007;71(4):893–899. doi:10.1271/bbb.6052117420580
   PubMed Web of Science ®Google Scholar
• NiY, NagashimadaM, ZhugeF, et al. Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: a comparison with vitamin E. Sci Rep. 2015;5(1):17192. doi:10.1038/srep1719226603489
   PubMed Web of Science ®Google Scholar
• KimB, FarruggiaC, KuCS, et al. Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis. J Nutr Biochem. 2017;43:27–35. doi:10.1016/j.jnutbio.2016.01.00628193580
   PubMed Web of Science ®Google Scholar
• ZhengH, LiS, MaL, et al. A novel agonist of PPAR-gamma based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance. Eur J Pharmacol. 2011;659(2–3):244–251. doi:10.1016/j.ejphar.2011.03.03321463618
   PubMed Web of Science ®Google Scholar
• CaoCY, LiYY, ZhouYJ, NieYQ, WanYJ. The C-681G polymorphism of the PPAR-gamma gene is associated with susceptibility to non-alcoholic fatty liver disease. Tohoku J Exp Med. 2012;227(4):253–262. doi:10.1620/tjem.227.25322820754
   PubMed Web of Science ®Google Scholar
• KoboriM, TakahashiY, SakuraiM, et al. Hepatic transcriptome profiles of mice with diet-induced nonalcoholic steatohepatitis treated with astaxanthin and vitamin E. Int J Mol Sci. 2017;18(3):593.
   PubMed Web of Science ®Google Scholar
• JiaY, WuC, KimJ, KimB, LeeSJ. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt. J Nutr Biochem. 2016;28:9–18. doi:10.1016/j.jnutbio.2015.09.01526878778
   PubMed Web of Science ®Google Scholar
• YangJP, ShinJH, SeoSH, KimSG, LeeSH, ShinEH. Effects of antioxidants in reducing accumulation of fat in hepatocyte. Int J Mol Sci. 2018;19(9):2563. doi:10.3390/ijms19092563
   PubMed Web of Science ®Google Scholar
• XuJ, RongS, GaoH, et al. A combination of flaxseed oil and astaxanthin improves hepatic lipid accumulation and reduces oxidative stress in high fat-diet fed rats. Nutrients. 2017;9(3):271. doi:10.3390/nu9030271
   PubMed Web of Science ®Google Scholar
• YangY, PhamTX, WegnerCJ, et al. Astaxanthin lowers plasma TAG concentrations and increases hepatic antioxidant gene expression in diet-induced obesity mice. Br J Nutr. 2014;112(11):1797–1804. doi:10.1017/S000711451400255425328157
   PubMed Web of Science ®Google Scholar
• YangY, SeoJM, NguyenA, et al. Astaxanthin-rich extract from the green alga Haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense in apolipoprotein E knockout mice. J Nutr. 2011;141(9):1611–1617. doi:10.3945/jn.111.14210921734060
   PubMed Web of Science ®Google Scholar
• ChoiHD, KimJH, ChangMJ, Kyu-YounY, ShinWG. Effects of astaxanthin on oxidative stress in overweight and obese adults. Phytother Res. 2011;25(12):1813–1818. doi:10.1002/ptr.349421480416
   PubMed Web of Science ®Google Scholar
• TranKT, ColemanHG, McCainRS, CardwellCR. Serum biomarkers of iron status and risk of primary liver cancer: a systematic review and meta-analysis. Nutr Cancer. 2019;71:1–9.30686054
   PubMed Web of Science ®Google Scholar
• GolfieriR, BargelliniI, SpreaficoC, TrevisaniF. Patients with barcelona clinic liver cancer stages B and C hepatocellular carcinoma: time for a subclassification. Liver Cancer. 2019;8(2):78–91. doi:10.1159/00048979131019899
   PubMed Web of Science ®Google Scholar
• GradeletS, AstorgP, Le BonAM, BergesR, SuschetetM. Modulation of aflatoxin B1 carcinogenicity, genotoxicity and metabolism in rat liver by dietary carotenoids: evidence for a protective effect of CYP1A inducers. Cancer Lett. 1997;114(1–2):221–223. doi:10.1016/S0304-3835(97)04668-59103297
   PubMed Web of Science ®Google Scholar
• TripathiDN, JenaGB. Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes. Mutat Res. 2010;696(1):69–80. doi:10.1016/j.mrgentox.2009.12.01420038455
   PubMed Web of Science ®Google Scholar
• SongX, WangM, ZhangL, et al. Changes in cell ultrastructure and inhibition of JAK1/STAT3 signaling pathway in CBRH-7919 cells with astaxanthin. Toxicol Mech Methods. 2012;22(9):679–686. doi:10.3109/15376516.2012.71711922889354
   PubMed Web of Science ®Google Scholar
• SongXD, ZhangJJ, WangMR, LiuWB, GuXB, LvCJ. Astaxanthin induces mitochondria-mediated apoptosis in rat hepatocellular carcinoma CBRH-7919 cells. Biol Pharm Bull. 2011;34(6):839–844. doi:10.1248/bpb.34.83921628881
   PubMed Web of Science ®Google Scholar
• ShaoY, NiY, YangJ, LinX, LiJ, ZhangL. Astaxanthin inhibits proliferation and induces apoptosis and cell cycle arrest of mice H22 hepatoma cells. Med Sci Monit. 2016;22:2152–2160. doi:10.12659/MSM.89941927333866
   PubMed Web of Science ®Google Scholar
• SaxenaNK, FuPP, NagalingamA, et al. Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology. 2010;139(5):1762–1773, 1773 e1761–1765. doi:10.1053/j.gastro.2010.07.001
   PubMed Web of Science ®Google Scholar
• OhnoT, ShimizuM, ShirakamiY, et al. Preventive effects of astaxanthin on diethylnitrosamine-induced liver tumorigenesis in C57/BL/KsJ-db/db obese mice. Hepatol Res. 2016;46(3):E201–E209. doi:10.1111/hepr.1255026147624
   PubMed Web of Science ®Google Scholar
• RodriguezWE, WahlangB, WangY, et al. PDE4 Inhibition as a therapeutic target for alcoholic liver disease: from bedside to bench. Hepatology. 2019;70(6):1958–1971. doi:10.1002/hep.3076131081957
   PubMed Web of Science ®Google Scholar
• BraunHJ, DodgeJL, GrabJD, et al. Living donor liver transplant for alcoholic liver disease: data from the adult to adult living donor liver transplantation study (A2ALL). Transplantation. 2019.
   Google Scholar
• LiuH, LiuH, ZhuL, et al. Comparative transcriptome analyses provide potential insights into the molecular mechanisms of astaxanthin in the protection against alcoholic liver disease in mice. Mar Drugs. 2019;17(3):181.
   PubMed Web of Science ®Google Scholar
• HanJH, JuJH, LeeYS, et al. Astaxanthin alleviated ethanol-induced liver injury by inhibition of oxidative stress and inflammatory responses via blocking of STAT3 activity. Sci Rep. 2018;8(1):14090.30237578
   PubMed Web of Science ®Google Scholar
• LiuH, LiuM, FuX, et al. Astaxanthin prevents alcoholic fatty liver disease by modulating mouse gut microbiota. Nutrients. 2018;10(9):1298.
   PubMed Web of Science ®Google Scholar
• WuYC, HuangHH, WuYJ, ManousakasI, YangCC, KuoSM. Therapeutic and protective effects of liposomal encapsulation of astaxanthin in mice with alcoholic liver fibrosis. Int J Mol Sci. 2019;20(16):4057.
   PubMed Web of Science ®Google Scholar
• TurkezH, GeyikogluF, YousefMI. Beneficial effect of astaxanthin on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced liver injury in rats. Toxicol Ind Health. 2013;29(7):591–599.22312033
   PubMed Web of Science ®Google Scholar
• TurkezH, GeyikogluF, YousefMI, et al. Hepatoprotective potential of astaxanthin against 2,3,7,8-tetrachlorodibenzo-p-dioxin in cultured rat hepatocytes. Toxicol Ind Health. 2014;30(2):101–112.22778115
   PubMed Web of Science ®Google Scholar
• LiJ, XiaY, LiuT, et al. Protective effects of astaxanthin on ConA-induced autoimmune hepatitis by the JNK/p-JNK pathway-mediated inhibition of autophagy and apoptosis. PLoS One. 2015;10(3):e0120440.25761053
   PubMed Web of Science ®Google Scholar
• ZhangJ, ZhangS, BiJ, GuJ, DengY, LiuC. Astaxanthin pretreatment attenuates acetaminophen-induced liver injury in mice. Int Immunopharmacol. 2017;45:26–33.28152447
   PubMed Web of Science ®Google Scholar
• WeiL, ChenWY, HuT, et al. Effect and mechanism of propofol in hepatic ischemia/reperfusion injury of rat. Eur Rev Med Pharmacol Sci. 2017;21(15):3516–3522.28829487
   PubMed Web of Science ®Google Scholar
• LiH, XiaZ, ChenY, QiD, ZhengH. Mechanism and therapies of oxidative stress-mediated cell death in ischemia reperfusion injury. Oxid Med Cell Longev. 2018;2018:2910643.30034574
   PubMed Web of Science ®Google Scholar
• YucelA, AydoganMS, UcarM, SariciKB, KaraaslanMG. Effects of apocynin on liver ischemia-reperfusion injury in rats. Transplant Proc. 2019;51(4):1180–1183.31101195
   PubMed Web of Science ®Google Scholar
• XueY, QuZ, FuJ, et al. The protective effect of astaxanthin on learning and memory deficits and oxidative stress in a mouse model of repeated cerebral ischemia/reperfusion. Brain Res Bull. 2017;131:221–228.28479214
   PubMed Web of Science ®Google Scholar
• PongkanW, TakatoriO, NiY, et al. beta-Cryptoxanthin exerts greater cardioprotective effects on cardiac ischemia-reperfusion injury than astaxanthin by attenuating mitochondrial dysfunction in mice. Mol Nutr Food Res. 2017;61(10):1601077.
   Web of Science ®Google Scholar
• OtsukaT, ShimazawaM, InoueY, et al. Astaxanthin protects against retinal damage: evidence from in vivo and in vitro retinal ischemia and reperfusion models. Curr Eye Res. 2016;41(11):1465–1472.27158842
   PubMed Web of Science ®Google Scholar
• CurekGD, CortA, YucelG, et al. Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion. Toxicology. 2010;267(1–3):147–153.19900500
   PubMed Web of Science ®Google Scholar
• LiJ, WangF, XiaY, et al. Astaxanthin pretreatment attenuates hepatic ischemia reperfusion-induced apoptosis and autophagy via the ROS/MAPK pathway in mice. Mar Drugs. 2015;13(6):3368–3387.26023842
   PubMed Web of Science ®Google Scholar
• LiS, TakaharaT, FujinoM, et al. Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice. PLoS One. 2017;12(11):e0187810.29121675
   PubMed Web of Science ®Google Scholar
• BhuvaneswariS, AnuradhaCV. Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. Can J Physiol Pharmacol. 2012;90(11):1544–1552.23181282
   PubMed Web of Science ®Google Scholar